These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25429651)

  • 21. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
    Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
    Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting oncogenes and tumor suppressors genes to mitigate chemoresistance.
    Fatemian T; Chowdhury EH
    Curr Cancer Drug Targets; 2014; 14(7):599-609. PubMed ID: 25308718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug retention, efflux, and resistance in tumor cells.
    Krishan A; Fitz CM; Andritsch I
    Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer.
    Cipponi A; Goode DL; Bedo J; McCabe MJ; Pajic M; Croucher DR; Rajal AG; Junankar SR; Saunders DN; Lobachevsky P; Papenfuss AT; Nessem D; Nobis M; Warren SC; Timpson P; Cowley M; Vargas AC; Qiu MR; Generali DG; Keerthikumar S; Nguyen U; Corcoran NM; Long GV; Blay JY; Thomas DM
    Science; 2020 Jun; 368(6495):1127-1131. PubMed ID: 32499442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMPK and Cancer.
    Wang Z; Wang N; Liu P; Xie X
    Exp Suppl; 2016; 107():203-226. PubMed ID: 27812982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of multidrug resistance in cancer.
    Gillet JP; Gottesman MM
    Methods Mol Biol; 2010; 596():47-76. PubMed ID: 19949920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversing agents for ATP-binding cassette drug transporters.
    Lee CH
    Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
    Shah K; Rawal RM
    Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic targeting of tumor suppressor genes.
    Morris LG; Chan TA
    Cancer; 2015 May; 121(9):1357-68. PubMed ID: 25557041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTOR Signaling Confers Resistance to Targeted Cancer Drugs.
    Guri Y; Hall MN
    Trends Cancer; 2016 Nov; 2(11):688-697. PubMed ID: 28741507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Up-to-date approaches to clinical estimate of phenotype of multiple drug resistance associated with function of ABC-transporters in human solid tumors].
    Bogush EA; Kirsanov VIu
    Antibiot Khimioter; 2006; 51(9-10):50-5. PubMed ID: 18030792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
    Wei N; Sun H; Liu GT
    Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer.
    Li Y; Revalde JL; Reid G; Paxton JW
    Drug Metab Rev; 2010 Nov; 42(4):590-611. PubMed ID: 20433315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Special Issue: New Approaches to Counteract Drug Resistance in Cancer.
    Vasconcelos MH
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28025535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of PTEN protein in multidrug resistance of prostate cancer cells].
    Sherbakova EA; Stromskaia TP; Rybalkina EIu; Kalita OV; Stavrovskaia AA
    Mol Biol (Mosk); 2008; 42(3):487-93. PubMed ID: 18702307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.